Latest Breaking News On - A narrow ruling on broad patent claims baxaltav genentech elongates the amgenv sanofi line of authority - Page 1 : comparemela.com
The United States Court of Appeals for the Federal Circuit recently delivered a precedential opinion in Baxalta v. Genentech, affirming the invalidity of patent claims directed to a genus of antibodies.